Nonlymphoblastic Leukemia, Acute
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Nonlymphoblastic Leukemia, Acute?
There are 1 clinical trial targeting Nonlymphoblastic Leukemia, Acute tracked by BioSniper.
What is the prevalence of Nonlymphoblastic Leukemia, Acute?
The estimated prevalence of Nonlymphoblastic Leukemia, Acute is approximately 30.0 per 100,000 population.
Deep-dive into Nonlymphoblastic Leukemia, Acute
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis